as on November 21, 2025 at 4:01 pm IST
Day's Low
0.34%
Downside
52 Week's Low
52 Week's High
15.69%
Downside
15.12%
Upside
as on November 21, 2025 at 4:01 pm IST
Market Cap
₹104.76 Cr
Return on Equity (ROE)
6.01
PE Ratio (TTM)
0Return on capital employed (ROCE)
8.98
Beta (LTM)
0.52
P/B Ratio
1.83
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
228
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bullish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Mercury Laboratories Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 104.76 | 18.31% | 0.00 | 3 | 75 | |
| NA | 421.81 | 22.01% | 0.00 | 10 | 150 | |
| NA | 32.65 | 100.22% | 0.00 | -1 | 50 | |
| BUY | 10,916.98 | -0.67% | 0.00 | 181 | 724 | |
| BUY | 21,295.05 | 293.7% | 0.55 | 260 | 1,476 |
Search interest for Mercury Laboratories Ltd Stock has increased by 83% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:83% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Mercury Laboratories Ltd.
Mercury Laboratories Ltd’s net profit jumped 228% since last year same period to ₹1.64Cr in the Q2 2025-2026. On a quarterly growth basis, Mercury Laboratories Ltd has generated 69.07% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Mercury Laboratories Ltd has declared dividend of ₹3.50 per share on 14 May 2025 - translating a dividend yield of 0.80%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, Mercury Labs stock has moved up by 2.5%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 26.34% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 16.4% return, outperforming this stock by 22.3%
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 125.5% return, outperforming this stock by 123.5%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 73.66% of holdings in Sep 2025 quarter
| Organisation | Mercury Laboratories Ltd |
| Headquarters | Vadodara |
| Industry | Pharmaceuticals |
| CEO | Divyakant Ramniklal Zaveri |
| E-voting on shares | Click here to vote |
Mercury Laboratories Ltd share price today stands at ₹873 as on at the close of the market. Mercury Laboratories Ltd share today touched a day high of ₹873 and a low of ₹870.
Mercury Laboratories Ltd touched a 52 week high of ₹1005 and a 52 week low of ₹736. Mercury Laboratories Ltd share price today i.e. is closed at ₹873, which is -13.13% down from its 52 week high and 18.61% up from its 52 week low.
Mercury Laboratories Ltd market capitalisation is ₹104.76 Cr as on .
To buy Mercury Laboratories Ltd shares, you need to follow these steps:
Mercury Laboratories Ltd trading volume is 2.00 as on . This means that 2.00 shares of Mercury Laboratories Ltd were bought and sold on the stock market during today's trading session.